We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

30 hedge funds and large institutions have $7.44M invested in TriSalus Life Sciences Warrant in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

15% more funds holding

Funds holding: 26 → 30 (+4)

8% less capital invested

Capital invested by funds: $8.05M → $7.44M (-$608K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
30
Holders Change
+4
Holders Change %
+15.38%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
2
Closed
3
Calls
$471K
Puts
–
Net Calls
+$471K
Net Calls Change
-$462K

Top Buyers

1
CS
Clear Street
New York
+$46.3K
2
PAMP
Polar Asset Management Partners
Ontario, Canada
+$21.9K
3
ZCA
Zeke Capital Advisors
Pennsylvania
+$12.7K
4
CM
CastleKnight Management
New York
+$8.87K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.47K

Top Sellers

1
QGA
Q Global Advisors
Texas
-$13K
2
MA
MYDA Advisors
New York
-$11K
3
MF
Magnetar Financial
Illinois
-$3.09K
4
Jane Street
Jane Street
New York
-$40
Name Holding Trade Value Shares
Change 		Change in
Stake
MP
1
Mangrove Partners
Connecticut
$4.92M – – –
RCM
2
Radcliffe Capital Management
Pennsylvania
$1.36M – – –
AGC
3
Angelo Gordon & Co
New York
$943K – – –
DM
4
Deerfield Management
New York
$28K – – –
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$24K +$21.9K +114,494 +67%
CS
6
Clear Street
New York
$20K +$46.3K +242,341 New
IM
7
Islet Management
New York
$14K – – –
KL
8
KIM LLC
Kansas
$14K +$32K +167,566 New
KC
9
Kepos Capital
New York
$12K – – –
VI
10
Vestcor Inc
New Brunswick, Canada
$12K – – –
MP
11
MSD Partners
New York
$11K – – –
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$11K – – –
Walleye Capital
13
Walleye Capital
New York
$9K – – –
Balyasny Asset Management
14
Balyasny Asset Management
Illinois
$8K – – –
BCL
15
Bracebridge Capital LLC
Massachusetts
$8K – – –
AA
16
AQR Arbitrage
Connecticut
$6K – – –
CCM
17
Context Capital Management
California
$6K – – –
SCM
18
Shaolin Capital Management
Florida
$6K – – –
ZCA
19
Zeke Capital Advisors
Pennsylvania
$6K +$12.7K +66,666 New
BCM
20
Basso Capital Management
Connecticut
$4K – – –
CM
21
CastleKnight Management
New York
$4K +$8.87K +46,371 New
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$2K +$4.47K +23,368 New
Jane Street
23
Jane Street
New York
$1K -$40 -207 -1%
HF
24
HRT Financial
New York
$1K – – –
Nomura Holdings
25
Nomura Holdings
Japan
$1K – – –
1
2

TLSIW Hedge Fund Activity: Q2 2022 in Review

30 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q2 2022, worth a combined $7.44M — down 7.6% from $8.05M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new TLSIW positions and 3 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Clear Street, opening a new position worth an estimated $46.3K. The largest seller was Q Global Advisors, exiting entirely with an estimated $13K sold.

  • 30 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q2 2022, up from 26 in Q1 2022.
  • Funds reported $7.44M of TriSalus Life Sciences Warrant stock for Q2 2022, down 7.6% quarter-over-quarter.
  • 7 funds opened new TriSalus Life Sciences Warrant positions in Q2 2022 and 3 closed out, a net change of +4 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q2 2022 was Clear Street, an estimated $46.3K added.
  • The largest TriSalus Life Sciences Warrant seller in Q2 2022 was Q Global Advisors, an estimated $13K sold.

Based on aggregated 13F filings for Q2 2022.